AstraZeneca Opens Cambridge Discovery Centre
AstraZeneca opened The Discovery Centre in November of 2021 in the United Kingdom. Designed by Herzog & de Meuron and BDP, the £1 billion R&D facility can accommodate over 2,200 investigators engaged in the creation of next-generation therapeutics and innovative precision medicines. Integrating advanced robotic and AI-driven technologies, the 580,000-sf project is strategically sited on the Cambridge Biomedical Campus to promote collaboration and convergence with neighboring institutions and industry partners.